Why is Wockhardt Ltd ?
- Poor long term growth as Net Sales has grown by an annual rate of 4.49% over the last 5 years
- Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.32
- The company has declared positive results for the last 3 consecutive quarters
- ROCE(HY) Highest at 7.47%
- OPERATING PROFIT TO INTEREST(Q) Highest at 4.50 times
- DEBT-EQUITY RATIO(HY) Lowest at 0.45 times
- The stock is trading at a discount compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of 30.54%, its profits have risen by 738.3% ; the PEG ratio of the company is 0.1
- Institutional investors have increased their stake by 0.53% over the previous quarter and collectively hold 18.09% of the company
- These investors have better capability and resources to analyse fundamentals of companies than most retail investors
How much should you hold?
- Overall Portfolio exposure to Wockhardt should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Wockhardt for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
Highest at 7.47%
Highest at 4.50 times
Lowest at 0.45 times
Highest at 5.74 times
Highest at Rs 965.00 cr
Highest at Rs 225.00 cr.
Highest at 23.32%
Highest at Rs 122.00 cr.
Highest at Rs 146.91 cr.
Highest at Rs 10.25
Here's what is working for Wockhardt
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
Operating Profit to Interest
Net Sales (Rs Cr)
Net Sales (Rs Cr)
Operating Profit (Rs Cr)
Operating Profit to Sales
PBT less Other Income (Rs Cr)
PAT (Rs Cr)
EPS (Rs)
Debt-Equity Ratio
Debtors Turnover Ratio
Here's what is not working for Wockhardt
Non Operating Income






